首页> 美国卫生研究院文献>Pharmaceutics >Development of New Strategies Using Extracellular Vesicles Loaded with Exogenous Nucleic Acid
【2h】

Development of New Strategies Using Extracellular Vesicles Loaded with Exogenous Nucleic Acid

机译:利用含有外源核酸的细胞外囊的开发新策略

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Gene therapy is a therapeutic strategy of delivering foreign genetic material (encoding for an important protein) into a patient’s target cell to replace a defective gene. Nucleic acids are embedded within the adeno-associated virus (AAVs) vectors; however, preexisting immunity to AAVs remains a significant concern that impairs their clinical application. Extracellular vesicles (EVs) hold great potential for therapeutic applications as vectors of nucleic acids due to their endogenous intercellular communication functions through their cargo delivery, including lipids and proteins. So far, small RNAs (siRNA and micro (mi)RNA) have been mainly loaded into EVs to treat several diseases, but the potential use of EVs to load and deliver exogenous plasmid DNA has not been thoroughly described. This review provides a comprehensive overview of the principal methodologies currently employed to load foreign genetic material into EVs, highlighting the need to find the most effective strategies for their successful clinical translation.
机译:基因治疗是将异物遗传物质(编码重要蛋白质)递送到患者的靶细胞中以取代缺陷基因的治疗策略。核酸嵌入在腺相关病毒(AAVS)载体内;然而,对AAV的抗药性预先存在的豁免仍然是损害其临床应用的重要令人担忧。细胞外囊泡(EVS)对治疗应用的巨大潜力作为核酸的载体,由于它们的内源性细胞间通信功能通过其货物递送,包括脂质和蛋白质。到目前为止,小RNA(siRNA和Micro(MI)RNA)主要是装载到EVS中以治疗几种疾病,但潜在使用EVS负载和输送外源性质粒DNA。本综述提供了全面概述目前用于将外来遗传物质加载到EV的主要方法,突出了需要找到最有效的临床翻译策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号